Next Article in Journal
Optimized Degradation and Inhibition of α-glucosidase Activity by Gracilaria lemaneiformis Polysaccharide and Its Production In Vitro
Next Article in Special Issue
First Insights into the Repertoire of Secretory Lectins in Rotifers
Previous Article in Journal
Development of Growth Media from Agricultural By-Products for Cultivation of PUFA-Producing Sicyoidochytrium minutum
Previous Article in Special Issue
A Novel C1q Domain-Containing Protein Isolated from the Mollusk Modiolus kurilensis Recognizing Glycans Enriched with Acidic Galactans and Mannans
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 20
Issue 1
10.3390/md20010010
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Bioactive Properties of Peptides and Polysaccharides Derived from Peanut Worms: A Review

by
Yi Qi
1,2,†,
Jingyi Zhou
1,†,
Xiaoqin Shen
3,
Meram Chalamaiah
4,
Simin Lv
5,
Hui Luo
1,2 and
Liang Chen
1,*
1
The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang 524023, China
2
Marine Chinese Medicine Branch, National Engineering Research Center for Modernization of Traditional Chinese Medicine, Zhanjiang 524023, China
3
College of Pharmacy, Guangdong Medical University, Zhanjiang 524023, China
4
4-10 Ag/For Centre, Department of Agricultural, Food and Nutritional Science (AFNS), University of Alberta, Edmonton, AB T6G 2P5, Canada
5
Guangdong Runyuan Zhongtian Biological Technology Co., Ltd., Dongguan 523808, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Mar. Drugs 2022, 20(1), 10; https://doi.org/10.3390/md20010010
Submission received: 27 November 2021 / Revised: 11 December 2021 / Accepted: 15 December 2021 / Published: 22 December 2021
(This article belongs to the Special Issue Marine Glycomics)
Browse Figure
Versions Notes

Abstract

:
Peanut worms (Sipunculids) are unsegmented marine worms that usually inhabit shallow waters. Peanut worms are good source of bioactive compounds including peptides and polysaccharides. Many recent studies have investigated the bioactive properties of peptides and polysaccharides derived from peanut worms in order to enhance their applications in food and pharmaceutical industries. The peptides and polysaccharides isolated from peanut worms have been reported to possess anti-hypertensive, anti-oxidant, immunomodulatory, anti-inflammatory, anti-cancer, anti-hypoxia and wound healing activities through the modulation of various molecular mechanisms. Most researchers used in vitro, cell culture and animal models for the determination of bioactivities of peanut worm derived compounds. However, studies in humans have not been performed considerably. Therefore, it is important to conduct more human studies for better utilization of marine bioactive compounds (peptides and polysaccharides) derived from peanut worms. This review mainly focuses on the bioactive properties of peptides and polysaccharides of peanut worms and their molecular mechanisms.

1. Introduction

Peanut worms are a group of unsegmented marine worms that belong to the invertebrate phylum Sipuncula. There are about 162 species of peanut worms. They are mostly under 10 cm long and live in shallow waters. Peanut worms are edible and considered as a delicacy in several southeast Asian countries including China, Philippines and Vietnam [1]. Some peanut worms (e.g., Sipunculus nudus) have been used in traditional Chinese medicine for the treatment/management of various ailments including hypertension, neurosis, coughing with dyspnea, nocturia, carbuncles, sternalgia, physical weakness, tuberculosis and regulating the functions of stomach and spleen [1,2].
Nutritional composition of foods plays an important role in providing essential nutrients for maintaining good health. The nutritional/chemical composition of peanut worms has been investigated [1,3]. The major components of peanut worms are proteins, carbohydrates and ash. For example, the protein content of P. esculenta was found to be 74.5% with high quality amino acids, and carbohydrates were 6.2% [3]. Since peanut worms contain significant quantities of nutritional and bioactive compounds, it is important to exploit the peanut worms for identification and isolation of active bioactive compounds for various food and pharmaceutical applications.
Many recent investigations have demonstrated the isolation of diverse peptides and polysaccharides, with various biological properties such as anti-oxidant, anti-cancer, immunomodulatory, anti-inflammatory and anti-hypertensive activities, from a number of marine organisms with great potential for industrial and therapeutic applications [4,5,6]. Food derived bioactive peptides are usually short chains of amino acids and generally possess 2–20 amino acid residues. Bioactive peptides are inactive within the sequence of parent protein. However, the bioactive peptides can be generated by using in vitro enzymatic hydrolysis, fermentation and during food processing and gastrointestinal digestion. In vitro enzymatic hydrolysis is the most widely used method for the production of bioactive peptides from various food sources. Bioactive peptides are easily digestible and absorbable with less or no side effects [7]. Therefore, recently bioactive peptides have attracted great interest among scientists and consumers due to their health benefiting properties [8]. Numerous bioactive peptides with diverse health promoting properties have been reported from various marine species and other food sources including fish, molluscs, crustaceans, algae, milk, egg and plant sources [7,9,10].
Polysaccharides are complex natural macromolecular polymers composed of monosaccharide units linked by glycosidic bonds. Polysaccharides are widely present in plants, animals, microorganisms and marine organisms and play a vital role in the development of living organisms [11]. In recent years, polysaccharides derived from natural sources have attracted great attention due to their biocompatibility, non-toxicity, biodegradability and applications in food and pharmaceutical industries [12]. It has been documented that polysaccharides isolated from natural edible sources exhibit significant bioactive properties [13].
Several recent studies have demonstrated that the peptides and polysaccharides obtained from peanut worms possessed numerous health benefiting functions, namely, anti-inflammatory, anti-hypertensive, immunomodulatory, anti-cancer, wound healing, anti-oxidant and anti-hypoxia activities [14,15,16,17,18,19,20] (Figure 1). However, the biological properties of peptides and polysaccharides of peanut worms have not been reviewed in the literature so far. This prompted the authors to review the literature on various bioactivities of peptides and polysaccharides derived from peanut worms and their molecular mechanisms of action.

2. Anti-Oxidative Properties of Peptides and Polysaccharides Derived from Peanut Worms

Cellular respiration in humans and other aerobic organisms generates reactive oxygen species (ROS) and free radicals. The anti-oxidant mechanisms (e.g., superoxide dismutase, catalase and glutathione peroxidase) in the body neutralize the excess production of free radicals and thereby maintain the balance between antioxidants and oxidative stress. The ROS and free radicals contain unpaired electrons and cause damage to important cellular components including lipids, proteins and DNA. The over production of ROS and free radicals has been linked to various diseases such as cancer, diabetes, atherosclerosis, Alzheimer disease and cardiovascular disorders [21,22,23]. Recently, there has been great interest in identification and isolation of anti-oxidant bioactive compounds from natural food sources (marine organisms, fish, milk, egg, algae, plant sources) due to their increased applications as safe alternatives to synthetic anti-oxidants in food and pharmaceutical industries.
Numerous peptides and polysaccharides with anti-oxidant activities have been identified and isolated from marine organisms for application as functional foods/health foods [24,25,26]. Peptides play an important role in the inhibition of free radicals and oxidative stress. It has been reported that the anti-oxidant mechanism of food originated peptides depends on composition, sequence and length [27,28]. Additionally, it was demonstrated that peptides with more hydrophobic (Ala, Val, Gly, Leu, Ile, Phe, Pro) amino acid residues can enhance anti-oxidant ability [15,29,30]. Most anti-oxidant peptides possess 3–15 amino acid residues [27,31,32,33,34]. Table 1 shows the molecular mechanisms of anti-oxidant peptides produced from various peanut worms.
There have been several investigations that reported the anti-oxidant capacity of peptides derived from peanut worms. The anti-oxidant activities exhibited by the peanut worms derived peptides were due to the inhibition of free radicals and enhancing the secretion of endogenous antioxidant enzymes such as SOD and glutathione peroxidase (GSH-Px). Zhu et al. [35] produced peptides from Sipunculus nudus by hydrolyzing with papain and found that peptides with molecular weight of 5868 Da showed excellent hydroxyl radical scavenging activity with 95% inhibition. Peptides generated from collagen of Phascolosoma esculenta have been reported to possess anti-oxidant capacity in vitro [36]. Liu et al. [15] prepared peptides (<3 kDa) from Phascolosoma esculenta by using pancreatin and investigated the anti-oxidant capacity of the peptides using mice model. It was found that peptide’s administration at 50, 100 and 150 mg/kg for 15 days dose-dependently improved the oxidative stress parameters such as GSH-Px, SOD, TAC and MDA in mice.
Apart from peptides, many studies have demonstrated that polysaccharides derived from peanut worms exhibit antioxidant activity through several ways including inhibition of DPPH, hydroxyl, superoxide free radicals, having reducing power, enhancing the antioxidant enzymes such as superoxide dismutase, glutathione peroxidase and upregulation of Nrf2 signaling pathway [16,19,37,38]. Anti-oxidant properties of polysaccharides produced from various peanut worms are presented in Table 2.
Researchers used various in vitro, and animal models to study the antioxidant capacity of polysaccharides derived from peanut worms. Studies conducted by Li et al. [39] and Qin et al. [37] documented that polysaccharides extracted from Sipunculus nudus showed a dose dependent inhibition of hydroxyl and superoxide radicals. Zhihao et al. [16] found that oligosaccharides from Phascolosoma esculenta exhibited anti-oxidative effects in sepsis mice model through the enhancement of enzyme activities of GSH-Px and SOD by activation of Nrf2 signaling pathway. Polysaccharide, composed of mannose, ribose, rhamnose, glucuronic acid, glucose, galactose, xylose, arabinose and fucose, derived from Phascolosoma esculenta have shown antioxidant activities in mice by enhancing superoxide dismutase (10–26%), glutathione peroxidase (11–30%) activities in serum and liver [38]. In a recent study, Yiqiao et al. [19] determined the radical scavenging activity and reducing power of polysaccharide isolated from Phascolosoma esculenta and reported the IC50 values of 0.567 and 0.605, 2.976 mg/mL respectively for DPPH and hydroxyl radicals and reducing power.
Most studies used in vitro and mice models for the determination of anti-oxidant activity of peptides and polysaccharides from peanut worms. However, cell culture and human studies are scanty. Therefore, further research is needed in humans and cells to verify the anti-oxidant benefits of these bioactive compounds of peanut worms.

3. Anti-Inflammatory Activities of Peptides and Polysaccharides Derived from Peanut Worms

Inflammation is a natural and complex defense mechanism of the immune system against a variety of harmful stimuli including pathogens, damaged cells, toxic chemicals, and irradiation. Generally, acute inflammation is beneficial to the body. However, chronic and uncontrolled inflammation can lead to various diseases such as cancer, diabetes, atherosclerosis, chronic kidney disease, arthritis and neurodegenerative disorders [40,41]. NSAIDs (non-steroidal anti-inflammatory drugs) are commonly used drugs for the treatment of inflammation. However, side effects associated with cardiovascular/renal/gastrointestinal systems have limited the application of NSAIDs. Therefore, recently there is a great interest in the use of food derived bioactive components (e.g., peptides and polysaccharides) for treatment or management of inflammation/inflammatory diseases due to their food origin and no/less side effects. Research has revealed that food derived bioactive compounds play an important role in the mitigation of inflammation/inflammatory diseases.
Numerous recent studies have shown that bioactive compounds (peptides, polyphenols, proteins, lipids and polysaccharides) derived from several food sources (fish, milk, egg, marine organisms and plant foods) possess anti-inflammatory properties [42,43,44,45,46]. Marine peanut worms have been investigated for anti-inflammatory compounds. Peptides and polysaccharides isolated from peanut worms have demonstrated to modulate the inflammatory response by inhibiting the production of pro-inflammatory mediators, TNF-α, IL-1β and TGF-β1, and reducing the activity of enzymes, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS).
Recently, anti-inflammatory peptides have been identified and isolated from few peanut worms after hydrolysis with proteolytic enzymes. Peptides isolated from Sipunculus nudus have shown anti-inflammatory effects through the modulation of several mechanisms such as reduction of expression of pro-inflammatory mediators, TNF-α, IL-1β, IL-6, iNOS and COX-2 and inhibition of NO production [1,20]. The anti-inflammatory effects of peptides isolated from peanut worms are presented in Table 3.
The food originated anti-inflammatory peptides are usually 2–10 amino acids in length. In addition to the peptide’s length, composition and sequence of peptides also play an important role in anti-inflammatory activity [47,48]. In recent years, researchers have documented the extraction of anti-inflammatory peptides from peanut worm, Sipunculus nudus. Sangtanoo et al. [1] isolated two peptides, LSPLLAAH (821.48 Da) and TVNLAYY (843.42 Da), from Sipunculus nudus after hydrolysis with neutrase, flavourzyme, and Alcalase and reported that both peptides showed strong anti-inflammatory activity in LPS-stimulated RAW264.7 macrophages by decreasing the expression of pro-inflammatory mediators, iNOS, IL-6, TNF-α and COX-2 after treatment with 30, 60, 120 mM for 12 h. In another recent study, Lin et al. [20] produced collagen peptides from Sipunculus nudus by using animal hydrolytic protease and flavor protease and demonstrated that peptides inhibited inflammation in the wound of mice skin through the reduction of mRNA levels of TGF-β1, TNF-α and IL-1β.
Apart from the peptides, the anti-inflammatory effects of polysaccharides isolated from peanut worms have also been studied considerably in recent years (Table 4). Chen-Xiao et al. [2] investigated the anti-inflammatory activities of water soluble polysaccharides of Sipunculus nudus using different mouse and rat models of inflammation. It was found that polysaccharide treatment at 50, 100 and 200 mg/kgBW for 6 days dose-dependently reduced the inflammation of carrageenan-induced paw oedema, dextran-induced rat paw oedema, carrageenan-induced peritonitis, xylene-induced ear oedema, and acetic acid-induced vascular permeability in mice. Zhihao et al. [16] extracted oligosaccharides, composed of D-glucosyl, and D-galactosyl residues with α- and β-type linkages, from Phascolosoma esculenta and demonstrated that administration of oligosaccharides at 1, 10 and 5 mg/mL for 30 days noticeably decreased the production of IL-1β and TNF-α and enhanced IL-10 in mice with sepsis induced inflammation.
The anti-inflammatory properties shown by the peptides and polysaccharides of peanut worms could be due to the suppression of nuclear factor kappa B (NF-κB) activation. Inhibition of NF-κB activation decreases the expression of COX-2 and iNOS and production of TNF-α and IL-1β, and therefore reduces inflammation. Though the anti-inflammatory activities have been reported for the peptides and polysaccharides of peanut worms, the underlying molecular mechanisms of anti-inflammatory activity have not been explored extensively so far. Therefore, further research is needed to determine the exact molecular mechanisms of action of these anti-inflammatory bioactive components (peptides and polysaccharides) isolated from peanut worms. This would enhance the applications of these bioactive compounds in food and pharmaceutical industries.

4. Anti-Hypertensive Activity of Peptides from Peanut Worms

Hypertension (high blood pressure) is a serious medical condition that affects 1280 million people globally aged between 30–79 years. It has been reported that several diseases related to heart (myocardial infarction, coronary heart disease), brain (stroke) and kidney (kidney failure) are linked to hypertension. Angiotensin I-converting enzyme (ACE; EC 3.4.15.1) plays an important role in regulation of blood pressure. ACE cleaves the two C-terminal dipeptides of inactive angiotensin I to produce angiotensin II, which is a potent vasoconstrictor that prevents the catalytic function of bradykinin, a vasodilator. Recent research has shown that inhibition of ACE with food derived peptides could be an effective way in the prevention/management of hypertension. It has been demonstrated that numerous peptides isolated from various food sources (milk, egg, fish, meat, marine organisms and vegetables) have shown anti-hypertensive activity [49,50,51,52,53,54,55,56,57].
Recently, several researchers investigated the anti-hypertensive effects of peptides derived from peanut worms such as Phascolosoma esculenta and Sipunculus nudus. Anti-hypertensive activities of peptides originated from peanut worms have been widely studied due to their excellent bioactive properties and safety profiles. Pepsin and trypsin are the two proteolytic enzymes that are extensively used in the production of anti-hypertensive peptides from peanut worms [3,17,58,59,60,61]. These enzymes specifically cleave the large molecular weight proteins into smaller peptides. The large proteins are usually unable to bind the active site of ACE, however, the smaller peptides generated by enzymatic hydrolysis could easily bind to the active site of ACE as inhibitor and thereby prevent high blood pressure [3]. It has been demonstrated that peptides derived from peanut worms showed anti-hypertensive activity through several mechanisms including changing the secondary structure of ACE, competitive and non-competitive inhibition of ACE, reducing systolic blood pressure and binding to the active sites of ACE [17,58,59,60] (Table 5).
The ACE inhibitory/antihypertensive activity of food derived peptides depends on the composition, sequence and length of the peptides. Peptides with more hydrophobic amino acids (aromatic and branched chain aliphatic) have been demonstrated to inhibit ACE efficiently [3]. Most of the ACE inhibitory peptides isolated from peanut worms contain 2–11 amino acids residues [17,58,59,60,62]. Du et al. [60] used pepsin to cleave the water soluble protein of Phascolosoma esculenta in order to obtain low molecular weight peptides with potent angiotensin I-converting enzyme (ACE) inhibitory activity. A novel ACE inhibitory peptide, Ala-Trp-Leu-His-Pro-Gly-Ala-Pro-Lys-Val-Phe, was isolated with IC50 value of 135 M. The authors investigated the inhibitory kinetics of the peptide and found that the identified peptide inhibited ACE through competitive inhibition. Furthermore, the peptide (Ala-Trp-Leu-His-Pro-Gly-Ala-Pro-Lys-Val-Phe) at 10 mg/kg dose showed anti-hypertensive effects in spontaneously hypertensive rats (SHR) by significantly decreasing the systolic blood pressure (SBP) around 30 mmHg. Water-soluble and insoluble proteins of P. esculenta were extracted, by Wu et al. [3], and the fractions hydrolyzed with pepsin and trypsin. The hydrolysates exhibited ACE inhibitory activity with IC50 values between 0.1 to 0.67 mg/mL. It was demonstrated that the peptides derived from water-soluble and insoluble proteins significantly reduced both diastolic blood pressure (DBP) (23–45 mmHg) and systolic blood pressure (SBP) (20–33 mmHg) in spontaneously hypertensive rats after single oral administration at a dose of 1 g/kgBW. Protein from Sipunculus nudus was hydrolysed with Protamex and three ACE inhibitory peptides IND, VEPG, and LADEF were isolated with IC50 values of 34.72, 20.55 and 22.77 μmol/L, respectively [62]. In another investigation, Guo et al. [59] identified and isolated three anti-hypertensive peptides, RYDF, YASGR and GNGSGYVSR, from Phascolosoma esculenta. It was found that the three peptides inhibited ACE through non-competitive inhibition with IC50 values between 29–235 μM. Furthermore, GNGSGYVSR reduced systolic blood pressure by 31 mmHg at 2 h after oral administration in spontaneously hypertensive rats. Recently, two novel ACE inhibitory peptides, GNGSGYV and SR, were reported from Phascolosoma esculenta after hydrolysis with pepsin and trypsin. The two peptides showed synergistic effect on ACE inhibition with IC50 value of 170 μM. The synergistic mechanism indicated that SR and GNGSGYV significantly changed the secondary structure of ACE. It was also found that the peptide SR initially formed a coordinate bond with the catalytic Zn of ACE and then GNGSGYV attached with arginine of dipeptide (SR) and the amino acids of ACE active site through hydrogen bonds and thereby prevent the substrate attachment with ACE [17]. In addition to the traditional hydrolysis, virtual hydrolysis of peanut worms has been performed by several researchers in order to identify the potential ACE inhibitory peptides. Hongxi et al. [61] virtually hydrolyzed Phascolosoma esculenta protein with pepsin and trypsin and identified five ACE inhibitory peptides, AYF, EL, GLR, HK and ILK, with IC50 values in the range of 3.43–4.18 U/mL. In another study, Liu et al. [58] conducted virtual hydrolysis of Phascolosoma esculenta with pepsin, trypsin and a mixture of pepsin and trypsin for identification of ACE inhibitory peptides and predicted that 284 di- and tri-peptides from Phascolosoma esculenta possess ACE inhibitory activity with IC50 less than 50 μM.
The research indicates that anti-hypertensive peptides obtained from peanut worms could be used as a natural component for application in health foods/nutraceuticals to prevent/treat hypertension. However, further research is needed on the exact molecular mechanisms of action of these anti-hypertensive peptides.

5. Immunomodulatory Activity of Polysaccharides Derived from Peanut Worms

Immune system is a complex defense network that protects the body against invading pathogens such as bacteria, viruses, fungi, protozoans, and prevents the growth of cancer cells. Immunomodulators are compounds that can potentially suppress or stimulate the immune system of host by modulating various immune cells and/or their signaling molecules (e.g., T cells, B cells, macrophages, NK cells, dendritic cells and cytokines) [63]. Recently, several polysaccharides with immunomodulatory activity have been identified from various food sources including mushrooms, fruits, cereals and algae [13].
Recent research has indicated that polysaccharides stimulate various immune cells (e.g., macrophages, NK cells, dendritic cells) by binding to the cell surface receptors such as Toll-like receptor 4 (TLR4), cluster of differentiation 14 (CD14), scavenger receptor (SR), complement receptor 3 (CR3), mannose receptor (MR) and Dectin-1 [13,63].
It has been demonstrated that polysaccharides derived from peanut worms exert immunomodulatory effects through various mechanisms such as activation of macrophages, increasing the indexes of immune organs (thymus and spleen), enhancing the secretion of cytokines, and improving the phagocytosis function of macrophages and NK cell activity [18,64,65,66]. Table 6 shows the immunomodulatory activities of polysaccharides derived from peanut worms.
A number of studies reported the immune stimulating activity of polysaccharides extracted from peanut worms, Sipunculus nudus and Phascolosoma esculenta. Liang et al. [64] investigated the immunomodulatory effects of polysaccharides from P. esulenta using a mice model and found that administration of polysaccharides at 3.0, 6.0, 9.0 mg/kgBW for 2 months considerably stimulated the Con-A activated mouse spleenocytes and increased the index of liver, spleen and thymus of mice. A water soluble polysaccharide, composed of rhamnose (28%), fucose (16%) and galactose (56%), extracted from Sipunculus nudus exhibited immunomodulatory effects by activating macrophages through the upregulation of expression of cytokines, IL-6 and TNF-α, and inducing the expression of iNOS and COX-2 [65]. Li et al. [66] reported that polysaccharides from Sipunculus nudus enhanced the cellular and humoral immunity in mice by increasing the phagocytosis function and NK cell activity. Su et al. [67] used hepatoma (HepG2) bearing mice model to study the immunomodulatory effects of polysaccharides derived from Sipunculus nudus. The mice were treated with 50, 100, and 200 mg/kg polysaccharide for 30 days and it was found that the polysaccharide composed of L-rhamnose, L-arabinose, D-ribose, D-glucose and D-galactose showed immune stimulating effects through increase of thymus and spleen indexes, and upregulated the IL-2, IFN-γ, and TNF-α cytokines in serum of mice. In another recent study, Su et al. [18] demonstrated that polysaccharide of Sipunculus nudus increased the index of immune organs and augmented the secretion of cytokines, IL-2, IFN-γ and TNF-α, in hepatoma mice after treatment with 50, 100 and 200 mg/kg polysaccharides for 16 days. These results suggest that immunomodulatory polysaccharides from peanut worms have great potential for application as nutraceutical/health foods.
Although immunomodulatory activities of polysaccharides derived from peanut worms have been documented, the molecular mechanisms of action and structure-function relationship of these polysaccharides have not been investigated. Thus, more research is needed on molecular mechanisms to decipher the immunomodulatory effects of these polysaccharides. Additionally, the immune stimulatory effects of peptides derived peanut worms need to be investigated considerably in order to enhance their application as health foods.

6. Anti-Cancer Activities of Polysaccharides Derived from Peanut Worms

Cancer is one of the major causes of death worldwide. Approximately 10 million deaths were occurred in 2020 due to various cancers [68]. Cancer is uncontrolled growth of cells in the body. The cancer cells attack the adjacent normal cells and spread to the other parts of the body. Currently, many different chemo drugs are used in the cancer treatment. However, side effects (neutropenia, nausea, vomiting, hair loss, blood clots etc.) associated with these drugs have limited their usage. Additionally, several chemotherapy drugs kill the normal cells along with the cancer cells. Therefore, recently there is great interest in finding new anti-cancer agents with less side effects from natural sources such as spices, vegetables, marine sources etc. [69,70]. Polysaccharides isolated from numerous natural resources including plant and marine sources have been reported to have inhibition activity on malignant cells primarily through the induction of apoptosis [71,72].
Polysaccharides extracted from peanut worms have been demonstrated to possess anti-cancer activity against cancer cells and in vivo animal models. Most researchers determined the anti-cancer effects of peanut worm derived polysaccharides in hepatocellular carcinoma. Scientific evidence from recent studies showed that polysaccharides derived from peanut worms exhibited anti-cancer effects by modulating numerous molecular mechanisms including preventing the DNA synthesis, increasing the expression of pro-apoptosis proteins, TNF-α, caspase-3, and Bax, decreasing the expression of the anti-apoptosis proteins, survivin, Bcl-2, and VEGF, up-regulation of caspase-3, caspase-8, and caspase-9, enhancing the expression of ATF4, DDIT3, and IkBα and reduction of CYR61, HSP90, and VEGF expression [18,67,73]. The mechanisms of action of anticancer activities of polysaccharides derived from peanut worms are presented in Table 7.
Polysaccharides isolated from peanut worm Sipunculus nudus have shown anti-cancer effects in cultured cancer cells and mice models with transplanted cancer cells. Jie et al. [73,74] studied the molecular mechanisms of anticancer effects of polysaccharides, extracted from Sipunculus nudus, after treating the Hepg2.2.15 cells with 0.13, 0.25, 0.5 and 1 mg/mL for 24 and 48 h and reported that Sipunculus nudus derived polysaccharides induced dose-dependent apoptosis on Hepg2.2.15 cells by increasing the expression of pro-apoptosis proteins, TNF-α, caspase-3, and Bax, and decreasing the expression of the anti-apoptosis proteins, survivin, Bcl-2, and VEGF. Su et al. [67] investigated the anti-cancer effects of polysaccharides of Sipunculus nudus using HepG2 cells-bearing mice model and demonstrated that administration of polysaccharides at 50, 100 and 200 mg/kg for 1 month significantly inhibited the growth of HepG2 cells through increasing the expression of ATF4, DDIT3 and IkBα and down-regulation of CYR61, HSP90 and VEGF expression. In another recent study, Su et al. [18] reported that polysaccharides extracted from Sipunculus nudus showed anti-cancer effects in HepG2-bearing mice by inducing the apoptosis of tumor cells through the up-regulation of caspase-3, caspase-8, caspase-9 and Bax, and down-regulation of B-cell lymphoma-2 and vascular endothelial growth factor protein expression.
The above scientific evidence confirmed that polysaccharides of peanut worms could inhibit the growth of the cancer cells. However, there are various limitations that could hamper the use of these polysaccharides for human applications as nutraceuticals/drugs. Firstly, more reliable and consistent scientific evidence from clinical studies about the beneficial effects of these polysaccharides is needed before its use for the treatment/management of cancer. Secondly, data about cytotoxic effects on normal cells and in-depth knowledge of exact molecular mechanisms of anti-cancer activity of peanut worms derived polysaccharides are required from cell culture, animal and clinical studies. Additionally, most studies investigated the anticancer activity of polysaccharides isolated from Sipunculus nudus, although there are many peanut worm species in phylum, Sipuncula. Therefore, anti-cancer activity for polysaccharides of other peanut worm species needs to be explored.

7. Other Bioactivities of Peanut Worm Derived Peptides and Polysaccharides

Apart from above mentioned bioactive properties, many researchers documented various other bioactive properties including wound healing capacity, memory improvement and anti-hypoxia activity for peanut worm derived peptides and polysaccharides (Table 8 and Table 9). Chen-Xiao and Zi-Ru [14] used various hypoxia mice models to determine the anti-hypoxia activity of polysaccharides extracted from Sipunculus nudus and revealed that polysaccharides showed significant anti-hypoxic activity on normobaric hypoxia, chemical intoxicant hypoxia and acute cerebral ischemia hypoxia models after treatment with 10, 30, 100 mg/kg for 6 days. Liu et al. [15] produced peptides < 3 kDa from Phascolosoma esculenta by using pancreatin and found that administration of peptides at 50, 100 and 150 mg/kg for 15 days improved the spatial learning and memory ability in mice through the up-regulation of NR2A, NR2B, BDNF and CREB mRNA expressions in hippocampus. Lin et al. [20] investigated the wound healing properties of collagen peptides derived from Sipunculus nudus and demonstrated that the peptides clearly improved the healing rate and inhibited scar formation in mice by enhancing collagen deposition and inhibition of TGF-β/Smads signaling pathway.

8. Conclusions

In this review, the various bioactive properties of peptides and polysaccharides originated from peanut worms were summarized. Peanut worms derived bioactive compounds (peptides and polysaccharides) exhibited anti-oxidant, anti-inflammatory, immunomodulatory, anti-hypertensive, anti-cancer and wound healing activities through the modulation of various molecular mechanisms. Most researchers investigated these bioactivities using in vitro, cell culture and animal models. Clinical studies confirming these bioactivities of peptides and polysaccharides of peanut worms are scanty in literature. Therefore, more clinical investigations are needed to enhance the applications of these bioactive compounds of peanut worms. Additionally, in-depth molecular mechanisms of action, bioavailability and safety profiles of these bioactive compounds of peanut worms need to be investigated thoroughly. Moreover, peptides produced from peanut worms could be further explored for their potential anti-diabetic, anti-microbial, anti-obesity and anti-atherosclerosis activities. Although there are several species in phylum sipuncula, only two species (Sipunculus nudus and Phascolosoma esculenta) have been investigated extensively with regard to the bioactive compound’s identification and isolation. Hence, other species of peanut worms could also be studied for possible identification of bioactive compounds for various human applications.

Author Contributions

Y.Q. and J.Z. prepared the original draft, X.S., S.L. and M.C. collected and analyzed the data, H.L. and L.C. revised manuscript and supervised the work. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the public service platform of South China Sea for R & D marine biomedicine resources (2017C8A), Zhanjiang Science and Technology Development Special Fund Project 2020A04005 and Guangdong province science and technology plan project (2HC19002).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

ACE: Angiotensin I-converting enzyme; ATF4: Activating transcription factor 4; Bcl-2: B-cell lymphoma 2; BDNF: Brain Derived Neurotrophic Factor; CD14: cluster of differentiation 14; COX-2: cyclooxygenase-2; CR3: complement receptor 3; CREB: cAMP responsive element binding protein; CYR61: Cysteine-rich angiogenic inducer 61; DBP: diastolic blood pressure; DDIT3:DNA Damage Inducible Transcript 3; DNA: Deoxyribonucleic acid; DPPH: 2,2-diphenyl-1-picrylhydrazyl; GPx: Glutathione peroxidase; GSH-Px: glutathione peroxidase; HaCaT: human immortalized keratinocytes; HSF: human skin fibroblasts; HSP90: Heat shock protein 90; HUVEC: human umbilical vein endothelial cells; IFN-γ: Interferon gamma; IL: interleukin; iNOS: inducible nitric oxide synthase; MDA: malondialdehyde; mRNA: messenger ribonucleic acid; MR: mannose receptor; NF-κB: nuclear factor kappa B; NK cells: Natural killer cells; NO: Nitric oxide; Nrf2: nuclear factor erythroid 2-related factor; NSAIDs: non-steroidal anti-inflammatory drugs; ROS: reactive oxygen species; SBP: systolic blood pressure; SR: scavenger receptor; SOD: superoxide dismutase; TAC: Totalantioxidantcapacity; TGF-β1: Transforming growth factor beta1; TLR4: Toll-like receptor 4; TNF-α: Tumour Necrosis Factor alpha; VEGF: Vascular endothelial growth factor.

References

  1. Sangtanoo, P.; Srimongkol, P.; Saisavoey, T.; Reamtong, O.; Karnchanatat, A. Anti-inflammatory action of two novel peptides derived from peanut worms (Sipunculus nudus) in lipopolysaccharide-induced RAW264.7 macrophages. Food Funct. 2020, 11, 552–560. [Google Scholar] [CrossRef] [PubMed]
  2. Zhang, C.X.; Dai, Z.R.; Cai, Q.X. Anti-inflammatory and anti-nociceptive activities of Sipunculus nudus L. extract. J. Ethnopharmacol. 2011, 137, 1177–1182. [Google Scholar] [CrossRef] [PubMed]
  3. Wu, Y.; Fang, M.; Du, L.; Wu, H.; Liu, Y.; Guo, M.; Xie, J.; Wei, D. The nutritional composition and anti-hypertensive activity on spontaneously hypertensive rats of sipuncula Phascolosoma esculenta. Food Funct. 2014, 5, 2317. [Google Scholar] [CrossRef] [PubMed]
  4. Ruiz-Ruiz, F.; Mancera-Andrade, E.I.; Iqbal, H.M. Marine-Derived Bioactive Peptides for Biomedical Sectors: A Review. Protein Pep. Lett. 2017, 24, 109–117. [Google Scholar] [CrossRef]
  5. Lee, Y.E.; Kim, H.; Seo, C.; Park, T.; Lee, K.B.; Yoo, S.Y.; Hong, S.C.; Kim, J.T.; Lee, J. Marine polysaccharides: Therapeutic efficacy and biomedical applications. Arch. Pharm. Res. 2017, 40, 1006–1020. [Google Scholar] [CrossRef] [PubMed]
  6. Zhong, Q.; Wei, B.; Wang, S.; Ke, S.; Chen, J.; Zhang, H.; Wang, H. The Antioxidant Activity of Polysaccharides Derived from Marine Organisms: An Overview. Mar. Drugs 2019, 17, 674. [Google Scholar] [CrossRef] [Green Version]
  7. Chalamaiah, M.; Yu, W.; Wu, J. Immunomodulatory and anticancer protein hydrolysates (peptides) from food proteins: A review. Food Chem. 2018, 245, 205–222. [Google Scholar] [CrossRef]
  8. Chalamaiah, M.; Ulug, S.K.; Hong, H.; Wu, J. Regulatory requirements of bioactive peptides (protein hydrolysates) from food proteins. J. Funct. Foods 2019, 58, 123–129. [Google Scholar] [CrossRef]
  9. Pádraigín, A.H.; Richard, J.G. Bioactive peptides from marine processing waste and shellfish: A review. J. Funct. Foods 2012, 4, 6–24. [Google Scholar]
  10. Wang, X.; Yu, H.; Xing, R.; Li, P. Characterization, preparation, and purification of marine bioactive peptides. BioMed Res. Int. 2017, 2017, 9746720. [Google Scholar] [CrossRef] [Green Version]
  11. Yu, Y.; Shen, M.; Song, Q.; Xie, J. Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review. Carbohydr. Polym. 2018, 183, 91–101. [Google Scholar] [CrossRef] [PubMed]
  12. Jun, L.; Stefan, W.; Chunlin, X. A review of bioactive plant polysaccharides: Biological activities, functionalization, and biomedical applications. Bioact. Carbohydr. Diet. Fibre 2015, 5, 31–61. [Google Scholar]
  13. Barbosa, J.R.; de Carvalho Junior, R.N. Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19. Trends Food Sci. Technol. 2021, 108, 223–235. [Google Scholar] [CrossRef] [PubMed]
  14. Zhang, C.X.; Dai, Z.R. Anti-hypoxia activity of a polysaccharide extracted from the Sipunculus nudus L. Int. J. Biol. Macromol. 2011, 49, 523–526. [Google Scholar] [CrossRef] [PubMed]
  15. Liu, L.; Cao, J.; Chen, J.; Zhang, X.; Wu, Z.; Xiang, H. Effects of peptides from Phascolosoma esculenta on spatial learning and memory via anti-oxidative character in mice. Neurosci. Lett. 2016, 631, 30–35. [Google Scholar] [CrossRef]
  16. Yang, Z.; Pan, Y.; Chen, J.; Zhang, H.; Wei, H.; Wu, Z.; Liu, L. Anti-inflammatory, anti-oxidative stress effect of Phascolosoma esculenta oligosaccharides on Escherichia coli-induced sepsis mice. Food Sci. Biotechnol. 2019, 28, 1871–1879. [Google Scholar] [CrossRef]
  17. Wu, J.; Xie, D.; Chen, X.; Tang, Y.J.; Wang, L.; Xie, J.; Wei, D. Inhibitory mechanism of a substrate-type angiotensin I-converting enzyme inhibitory peptide. Proc. Biochem. 2019, 79, 97–104. [Google Scholar] [CrossRef]
  18. Su, J.; Liao, D.; Su, Y.; Liu, S.; Jiang, L.; Wu, J.; Liu, Z.; Wu, Y. Novel polysaccharide extracted from Sipunculus nudus inhibits HepG2 tumour growth in vivo by enhancing immune function and inducing tumour cell apoptosis. J. Cell. Mol. Med. 2021, 25, 8338–8351. [Google Scholar] [CrossRef] [PubMed]
  19. Lu, Y.; Chi, H.; Li, G.; Chen, Q.; Qiu, J.; Yu, H.; Fang, X.; Chen, X. Study on alkaline extraction process optimization of polysaccharides from coelomic fluid of Phasolosma esculenta and its antioxidant activity in vitro. Sci. Technol. Food Ind. 2021, 42, 204–210. [Google Scholar]
  20. Lin, H.; Zheng, Z.; Yuan, J.; Zhang, C.; Cao, W.; Qin, X. Collagen peptides derived from Sipunculus nudus accelerate wound healing. Molecules 2021, 26, 1385. [Google Scholar] [CrossRef] [PubMed]
  21. Pizzino, G.; Irrera, N.; Cucinotta, M.; Pallio, G.; Mannino, F.; Arcoraci, V.; Squadrito, F.; Altavilla, D.; Bitto, A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell. Longev. 2017, 2017, 8416763. [Google Scholar] [CrossRef]
  22. Sharifi-Rad, M.; Anil Kumar, N.V.; Zucca, P.; Varoni, E.M.; Dini, L.; Panzarini, E.; Rajkovic, J.; Fokou, P.V.T.; Azzini, E.; Peluso, I.; et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front. Physiol. 2020, 11, 694. [Google Scholar] [CrossRef] [PubMed]
  23. Forman, H.J.; Zhang, H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021, 20, 689–709. [Google Scholar] [CrossRef]
  24. Cheung, R.C.; Ng, T.B.; Wong, J.H. Marine peptides: Bioactivities and applications. Mar. Drugs 2015, 13, 4006–4043. [Google Scholar] [CrossRef]
  25. Ruocco, N.; Costantini, S.; Guariniello, S.; Costantini, M. Polysaccharides from the marine environment with pharmacological, cosmeceutical and nutraceutical potential. Molecules 2016, 21, 551. [Google Scholar] [CrossRef]
  26. Lafarga, T.; Acién-Fernández, F.G.; Garcia-Vaquero, M. Bioactive peptides and carbohydrates from seaweed for food applications: Natural occurrence, isolation, purification, and identification. Algal Res. 2020, 48, 101909. [Google Scholar] [CrossRef]
  27. Nwachukwu, I.D.; Aluko, R.E. Structural and functional properties of food protein-derived antioxidant peptides. J. Food Biochem. 2019, 43, e12761. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Kai, W.; Han, L.; Hong, H.; Pan, J.; Liu, H.; Luo, Y. Purification and identification of novel antioxidant peptides from silver carp muscle hydrolysate after simulated gastrointestinal digestion and transepithelial transport. Food Chem. 2021, 342, 128275. [Google Scholar]
  29. Chalamaiah, M.; Dinesh Kumar, B.; Hemalatha, R.; Jyothirmayi, T. Fish protein hydrolysates: Proximate composition, amino acid composition, antioxidant activities and applications: A review. Food Chem. 2012, 135, 3020–3038. [Google Scholar] [CrossRef]
  30. Liu, W.Y.; Zhang, J.T.; Miyakawa, T.; Li, G.M.; Gu, R.Z.; Tanokura, M. Antioxidant properties and inhibition of angiotensin-converting enzyme by highly active peptides from wheat gluten. Sci. Rep. 2021, 11, 5206. [Google Scholar] [CrossRef] [PubMed]
  31. Tadesse, S.A.; Emire, S.A. Production and processing of antioxidant bioactive peptides: A driving force for the functional food market. Heliyon 2020, 6, e04765. [Google Scholar] [CrossRef]
  32. Fernando, I.P.S.; Park, S.Y.; Han, E.J.; Kim, H.S.; Kang, D.S.; Je, J.Y.; Ahn, C.B.; Ahn, G. Isolation of an antioxidant peptide from krill protein hydrolysates as a novel agent with potential hepatoprotective effects. J. Funct. Foods 2020, 67, 103889. [Google Scholar] [CrossRef]
  33. Tonolo, F.; Folda, A.; Cesaro, L.; Scalcon, V.; Marin, O.; Ferro, S.; Bindoli, A.; Rigobello, M.P. Milk-derived bioactive peptides exhibit antioxidant activity through the Keap1-Nrf2 signaling pathway. J. Funct. Foods 2020, 64, 103696. [Google Scholar] [CrossRef]
  34. Zhang, J.; Li, M.; Zhang, G.; Tian, Y.; Kong, F.; Xiong, S.; Zhao, S.; Jia, D.; Manyande, A.; Du, H. Identification of novel antioxidant peptides from snakehead (Channa argus) soup generated during gastrointestinal digestion and insights into the anti-oxidation mechanisms. Food Chem. 2021, 337, 127921. [Google Scholar] [CrossRef]
  35. Zhu, Y.L.; Li, S.D.; Liao, Y.; Li, J.M. Made polypeptide from Sipunculus nudus by papain enzymolysis and its effects on hydroxy radical cleaning. Adv. Mater. Res. 2013, 699, 360–366. [Google Scholar] [CrossRef]
  36. Xiang, H.; Liu, L.; Lu, X.; Shi, Y.; Chen, J. Optimization of the preparation of collagen antioxidant peptide of Phascolosoma esculenta by response surface method. Sci. Technol. Food Ind. 2014, 13, 253–257. [Google Scholar]
  37. Zhang, Q.; Dong, L.; Tong, T.; Wang, Q.; Xu, M. Polysaccharides in Sipunculus nudus: Extraction condition optimization and antioxidant activities. J. Ocean Univ. China 2017, 16, 74–80. [Google Scholar] [CrossRef]
  38. Wu, Y.; Jiang, H.; Lin, J.S.; Liu, J.; Wu, C.J.; Xu, R. Antioxidant, hypolipidemic and hepatic protective activities of polysaccharides from Phascolosoma esculenta. Mar. Drugs 2020, 18, 158. [Google Scholar] [CrossRef] [Green Version]
  39. Li, N.; Shen, X.; Liu, Y.; Zhang, J.; He, Y.; Liu, Q.; Jiang, D.; Zong, J.; Li, J.; Hou, D.; et al. Isolation, characterization, and radiation protection of Sipunculus nudus L. polysaccharide. Int. J. Biol. Macromol. 2016, 83, 288–296. [Google Scholar] [CrossRef] [PubMed]
  40. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018, 9, 7204–7218. [Google Scholar] [CrossRef] [Green Version]
  41. Furman, D.; Campisi, J.; Verdin, E.; Carrera-Bastos, P.; Targ, S.; Franceschi, C.; Ferrucci, L.; Gilroy, D.W.; Fasano, A.; Miller, G.W.; et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 2019, 25, 1822–1832. [Google Scholar] [CrossRef]
  42. Lordan, R.; Zabetakis, I. Invited review: The anti-inflammatory properties of dairy lipids. J. Dairy Sci. 2017, 100, 4197–4212. [Google Scholar] [CrossRef] [PubMed]
  43. Yahfoufi, N.; Alsadi, N.; Jambi, M.; Matar, C. The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients 2018, 10, 1618. [Google Scholar] [CrossRef] [Green Version]
  44. Sun, J.; Gou, Y.; Liu, J.; Chen, H.; Kan, J.; Qian, C.; Zhang, N.; Niu, F.; Jin, C. Anti-inflammatory activity of a water-soluble polysaccharide from the roots of purple sweet potato. RSC Adv. 2020, 10, 39673–39686. [Google Scholar] [CrossRef]
  45. Liang, Q.; Chalamaiah, M.; Liao, W.; Ren, X.; Ma, H.; Wu, J. Zein hydrolysate and its peptides exert anti-inflammatory activity on endothelial cells by preventing TNF-α-induced NF-κB activation. J. Funct. Foods 2020, 64, 103598. [Google Scholar] [CrossRef]
  46. Wang, Y.; Zhu, H.; Wang, X.; Yu, Y.; Xie, J. Natural food polysaccharides ameliorate inflammatory bowel disease and its mechanisms. Foods 2021, 10, 1288. [Google Scholar] [CrossRef]
  47. Snigdha, G.; Kaustav, M. Structural-features of food-derived bioactive peptides with anti-inflammatory activity: A brief review. J. Food Biochem. 2018, 43, e12531. [Google Scholar]
  48. Zhu, W.; Ren, L.; Zhang, L.; Qiao, Q.; Farooq, M.Z.; Xu, Q. The Potential of Food Protein-Derived Bioactive Peptides against Chronic Intestinal Inflammation. Mediat. Inflamm. 2020, 2020, 6817156. [Google Scholar] [CrossRef]
  49. Seung, Y.L.; Sun, J.H. Antihypertensive peptides from animal products, marine organisms, and plants. Food Chem. 2017, 228, 506–517. [Google Scholar]
  50. Mirzapour, M.; Rezaei, K.; Sentandreu, M.A. Identification of potent ACE inhibitory peptides from wild almond proteins. J. Food Sci. 2017, 82, 2421–2431. [Google Scholar] [CrossRef]
  51. Ola, A.; Moncef, N. Basic and recent advances in marine antihypertensive peptides: Production, structure-activity relationship and bioavailability. Trends Food Sci. Technol. 2019, 88, 543–557. [Google Scholar]
  52. Abachi, S.; Bazinet, L.; Beaulieu, L. Antihypertensive and angiotensin-I-converting enzyme (ACE)-inhibitory peptides from fish as potential cardioprotective compounds. Mar. Drugs 2019, 17, 613. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Agustina, E.N.; Santiago, S.; Alejandra, V.Q.; Maria, C.A. Amaranth as a source of antihypertensive peptides. Front. Plant Sci. 2020, 11, 578631. [Google Scholar]
  54. Yu, Z.; Guo, H.; Shiuan, D.; Xia, C.; Zhao, W.; Ding, L.; Zheng, F.; Liu, J. Interaction mechanism of egg white-derived ACE inhibitory peptide TNGIIR with ACE and its effect on the expression of ACE and AT1 receptor. Food Sci. Hum. Wellness 2020, 9, 52–57. [Google Scholar] [CrossRef]
  55. Durak, M.Z.; Neslihan, A.T. Antihypertensive Peptides in Dairy Products. Am. J. Biomed. Sci. Res. 2020, 7, 191–195. [Google Scholar] [CrossRef] [Green Version]
  56. Arshdeep, K.; Bababode, A.; Poorva, S.; Deepansh, S.; Sawinder, K. Recently isolated food-derived antihypertensive hydrolysates and peptides: A review. Food Chem. 2021, 346, 128719. [Google Scholar]
  57. Ma, K.; Wang, Y.; Wang, M.; Wang, Z.; Wang, X.; Ju, X.; He, R. Antihypertensive activity of the ACE–renin inhibitory peptide derived from Moringa oleifera protein. Food Funct. 2021, 12, 8994–9006. [Google Scholar] [CrossRef]
  58. Liu, Y.; Zhang, L.; Guo, M.; Wu, H.; Xie, J.; Wei, D. Virtual screening for angiotensin I-converting enzyme inhibitory peptides from Phascolosoma esculenta. Bioresour. Bioprocess. 2014, 1, 17. [Google Scholar] [CrossRef] [Green Version]
  59. Guo, M.; Chen, X.; Wu, Y.; Zhang, L.; Huang, W.; Yuan, Y.; Fang, M.; Xie, J.; Wei, D. Angiotensin I-converting enzyme inhibitory peptides from Sipuncula (Phascolosoma esculenta): Purification, identification, molecular docking and antihypertensive effects on spontaneously hypertensive rats. Proc. Biochem. 2017, 63, 84–95. [Google Scholar] [CrossRef]
  60. Du, L.; Fang, M.; Wu, H.; Xie, J.; Wu, Y.; Li, P.; Zhang, D.; Huang, Z.; Xia, Y.; Zhou, L.; et al. A novel angiotensin I-converting enzyme inhibitory peptide from Phascolosoma esculenta water-soluble protein hydrolysate. J. Funct. Foods 2013, 5, 475–483. [Google Scholar] [CrossRef]
  61. Wu, H.; Liu, Y.; Guo, M.; Xie, J.; Jiang, X. A virtual screening method for inhibitory peptides of angiotensin I–converting enzyme. J. Food Sci. 2014, 79, C1635. [Google Scholar] [CrossRef]
  62. Sun, X.; Wang, M.; Liu, B.; Sun, Z. Purification and characterization of angiotensin I converting enzyme inhibition peptides from Sandworm Sipunculus nudus. J. Ocean Univ. China 2017, 16, 911–915. [Google Scholar] [CrossRef]
  63. Yin, M.; Zhang, Y.; Li, H. Advances in research on immunoregulation of macrophages by plant polysaccharides. Front. Immunol. 2019, 10, 145. [Google Scholar] [CrossRef] [Green Version]
  64. Liang, R. Orthogonal test design for optimization of the extraction of polysaccharides from Phascolosoma esulenta and evaluation of its immunity activity. Carbohydr. Polym. 2008, 73, 558–563. [Google Scholar]
  65. Zhang, C.X.; Dai, Z.R. Immunomodulatory activities on macrophage of a polysaccharide from Sipunculus nudus L. Food Chem. Toxicol. 2011, 49, 2961–2967. [Google Scholar] [CrossRef] [PubMed]
  66. Li, K.X.; Shen, X.R.; He, Y.; Jiang, D.W.; Liu, Y.M.; Hou, D.Y.; Chen, W. Effect of Sipunculus nudus polysaccharides on immunological function in mice. Chin. J. Mar. Drugs 2012, 31, 46–49. [Google Scholar]
  67. Su, J.; Jiang, L.; Wu, J.; Liu, Z.; Wu, Y. Immunologic effect of polysaccharides extracted from Sipunculus nudus (SNP) on Hepatoma HepG2-bearing Mice. bioRxiv 2017, 10, 175190. [Google Scholar] [CrossRef] [Green Version]
  68. Ferlay, J.; Ervik, M.; Lam, F.; Colombet, M.; Mery, L.; Piñeros, M.; Znaor, A.; Soerjomataram, I.; Bray, F. Global Cancer Observatory: Cancer Today; International Agency for Research on Cancer: Lyon, France, 2020; Available online: https://gco.iarc.fr/today (accessed on 5 February 2021).
  69. Pucci, C.; Martinelli, C.; Ciofani, G. Innovative approaches for cancer treatment: Current perspectives and new challenges. eCancer Med. Sci. 2019, 13, 961. [Google Scholar] [CrossRef]
  70. Khalifa, S.; Elias, N.; Farag, M.A.; Chen, L.; Saeed, A.; Hegazy, M.F.; Moustafa, M.S.; Abd El-Wahed, A.; Al-Mousawi, S.M.; Musharraf, S.G.; et al. Marine natural products: A source of novel anticancer drugs. Mar. Drugs 2019, 17, 491. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Alves, C.; Silva, J.; Pinteus, S.; Gaspar, H.; Alpoim, M.C.; Botana, L.M.; Pedrosa, R. From marine origin to therapeutics: The antitumor potential of marine algae-derived compounds. Front. Pharmacol. 2018, 9, 777. [Google Scholar] [CrossRef] [Green Version]
  72. Khan, T.; Date, A.; Chawda, H.; Patel, K. Polysaccharides as potential anticancer agents-A review of their progress. Carbohydr. Polym. 2019, 210, 412–428. [Google Scholar] [CrossRef] [PubMed]
  73. Su, J.; Jiang, L.L.; Wu, J.N.; Liu, Z.Y.; Wu, Y.P. Anti-tumor and anti-virus activity of polysaccharides extracted from Sipunculus nudus (SNP) on Hepg2.2.15. Int. J. Biol. Macromol. 2016, 87, 597–602. [Google Scholar] [CrossRef] [PubMed]
  74. Chen, W.; Wang, X.; Shao, D.; Li, L.; Huang, Y.; Sun, H.; Li, L.; Lin, Y. Study on extraction process of Sipunculus nudus polysaccharide and its antioxidant activity. Agric. Biotechnol. 2018, 7, 112–118. [Google Scholar]
Marinedrugs 20 00010 g001 550
Figure 1. Various major bioactivities of peptides and polysaccharides derived from peanut worms.
Figure 1. Various major bioactivities of peptides and polysaccharides derived from peanut worms.
Marinedrugs 20 00010 g001
Table
Table 1. Molecular mechanisms of anti-oxidant peptides derived from peanut worms.
Table 1. Molecular mechanisms of anti-oxidant peptides derived from peanut worms.
Peanut Worm NameEnzyme Used to Produce PeptidesPeptide Sequence and Molecular WeightIn Vitro/Cell Culture/Animals/Humans Used for the StudyDose and DurationMechanism of Action/
Activities/Effects Showed		Ref.
Sipunculus nudusPapainPeptides 5868 DaIn vitro hydroxyl Radical scavenging activity-------The polypeptide showed great hydroxyl radical scavenging activity with 95.42% inhibition.[35]
Phascolosoma esculentaPancreatinPeptides < 3 kDaMice50, 100 and 150 mg/kg for 15 daysPeptides dose-dependently improved the oxidative stress status (GSH-Px, SOD, TAC andMDA) in mice[15]
Phascolosoma esculentaPapain-----------In vitro total anti-oxidant capacity---------Collagen peptides from Phascolosoma esculenta showed total anti-oxidant capacity with 3.8 U/mg[36]
Table
Table 2. Molecular mechanisms of anti-oxidant activities of polysaccharides derived from various peanut worms.
Table 2. Molecular mechanisms of anti-oxidant activities of polysaccharides derived from various peanut worms.
SourceComposition of Polysaccharide ExtractCell Culture/
Animal Models		Dose and DurationMolecular Mechanisms/EffectsRef.
Sipunculus nudusPolysaccharide was com-posed of mannose, rhamnose, galacturonic acid, glucose, arabinose and fucoseIn vitro hydroxyl radical activity.0.25, 0.5, 1.0, 2.0, 5.0,10.0, 20.0 mg/mL for 30 minPolysaccharide showed powerful scavenging activity on hydroxyl radical in a dose dependent manner.[39]
Sipunculus nudus-----------------In vitro reducing power, hydroxyl and superoxide radicals inhibition assay200–1000 µg/mL for 30 minS. nudus polysaccharides showed dose dependent inhibition of hydroxyl and superoxide radicals and exhibited great reducing power.[37]
Phascolosoma esculentaD-glucosyl, D-galactosyl, with small amount of D-mannosyl, D-arabinosyl and residues with a- and b-type linkage.Mice1, 10 and 5 mg/mL for 30 daysOligosaccharides from Phascolosoma esculenta enhanced the enzyme activities of GSH-Px and SOD by upregulating Nrf2 mRNA expression in sepsis mice model.[16]
Phascolosoma esculentaMannose, ribose, rhamnose,
glucuronic acid, glucose, galactose, xylose, arabinose and fucose		In vitro DPPH, superoxide
anion, hydroxyl radicals and ferrous ion chelating and mice model		0.2, 0.4 and 0.8 g/kgBW for 25 dPolysaccharides from Phascolosoma esculenta scavenged free radicals dose-dependently and showed antioxidant activities in mice by enhancing superoxide dismutase (SOD) (10.2–22.2% and 18.8–26.9%), glutathione peroxidase (GSH-Px) (11.9–15.4% and 26.6–30.4%) activities in serum and liver.[38]
Sipunculus nudus-----------In vitro DPPH and hydroxyl radical scavenging activities0.2 mg/mLFree radical scavenging rates increased significantly with the increase of concentration. The scavenging activities of hydroxyl radical and DPPH radical were found to be
12.58% at the concentration of 0.20 mg/mL.		[39]
Phascolosoma esculentapolysaccharide contained glucose with acetylaminoand pyran rings and connected by α-glycosidic bondsIn vitro reducing power, DPPH and hydroxyl radical scavenging activities1,5,10,15,20, and 25 mg/mL for 30 minPolysaccharide showed DPPH and hydroxyl radical scavenging and reducing power with IC50 of 0.567 and 0.605, 2.976 mg/mL, respectively.[19]
Table
Table 3. Molecular mechanisms of anti-inflammatory peptides derived from peanut worms.
Table 3. Molecular mechanisms of anti-inflammatory peptides derived from peanut worms.
Peanut Worm NameEnzyme Used to Produce PeptidesPeptide Sequence and Molecular WeightIn Vitro/Cell Culture/Animals/Humans Used for the StudyDose and DurationMechanism of Action/Activities/Effects ShowedRef.
Sipunculus nudusNeutrase, Flavourzyme, and AlcalaseLSPLLAAH (821.48 Da) and TVNLAYY (843.42 Da).RAW 264.7 macrophages30, 60, 120 mm for 12 hPeptides (LSPLLAAH and TVNLAYY) inhibited NO production and decreased the expression of pro-inflammatory mediators, iNOS, IL-6, TNF-α, and COX-2, in LPS-stimulated RAW264.7 macrophages.[1]
Sipunculus
nudus		Animal hydrolytic protease (3000 U/g) and flavor proteaseCollagen peptides < 5 kDaMice2 g/mL for 7 daysPeptides showed anti-inflammatory activity through the reduction of mRNA levels of TGF-β1, TNF-α and IL-1β in the wound of mice skin.[20]
Table
Table 4. Molecular mechanisms of anti-inflammatory activity of polysaccharides derived from various peanut worms.
Table 4. Molecular mechanisms of anti-inflammatory activity of polysaccharides derived from various peanut worms.
SourceComposition of Polysaccharide ExtractCell Culture/
Animal Models		Dose and DurationMolecular Mechanisms/EffectsRef.
Sipunculus nudusWater extractMouse and rat oedema paw models50, 100 and 200 mg/kg for 6 daysWater extract from the body wall of Sipunculus nudus showed dose-dependent anti-inflammatory activity in the carrageenan-induced paw oedema, dextran-induced rat paw oedema, cotton pellet granuloma, carrageenan-induced peritonitis, xylene-induced ear oedema, and acetic acid-induced vascular permeability models.[2]
Phascolosoma esculentaD-glucosyl, D-galactosyl, with small amount of D-mannosyl, D-arabinosyl and residues with α- and β-type linkage.Mice1, 10 and 5 mg/mL for 30 daysOligosaccharides from Phascolosoma esculenta considerably decreased the secretion of IL-1β and TNF-α and enhanced the IL-10 in sepsis mice.[16]
Table
Table 5. Molecular mechanisms of action of ACE-inhibitory/anti-hypertensive peptides derived from various peanut worms.
Table 5. Molecular mechanisms of action of ACE-inhibitory/anti-hypertensive peptides derived from various peanut worms.
Peanut Worm NameEnzyme Employed to Produce PeptidesPeptide Sequence and Molecular WeightIn Vitro/Cell Culture/Animals/Humans Used for the StudyIC50/EC50
Values		Activity/Mechanisms of Action ShowedRef.
Phascolosoma esculentaPepsinAWLHPGAPKVFIn vitro ACE inhibition assay & spontaneously hypertensive ratsIC50 value of 135 MPeptide inhibited ACE through competitive inhibition and exhibited anti-hypertensive effects in rats by significantly reducing the systolic blood pressure around 30 mmHg.[60]
Phascolosoma esculentaPepsin and trypsin----------------In vitro ACE inhibition assay & spontaneously hypertensive ratsIC50 values of 0.67 and 0.24 mg/mLPeptides significantly reduced both diastolic blood pressure (DBP) and systolic blood pressure (SBP) and inhibited ACE in vitro.[3]
Phascolosoma esculentaPepsin, and trypsinAYF, EL, GLR, HK, and ILKIn vitro ACE inhibition assayIC50 values of 3.43–4.18 U/mlPeptides exhibited ACE inhibitory activity with IC50 values in the range of 3.43–4.18 U/mL[61]
Phascolosoma esculentaPepsin and trypsin284 di- and tri-peptidesIn vitro ACE inhibition assayIC50 less than 50 μMPeptides inhibited the ACE.[58]
Sipunculus nudusProtamexIND, VEPG, LADEFIn vitro ACE inhibition assayIC50 values for ACE inhibition were 34.72, 20.55 and 22.77 μmol/LThe peptides IND, VEPG, and LADEF showed ACE inhibition activity with IC50 values of 34.72, 20.55 and 22.77 μmol/L, respectively.[62]
Phascolosoma esculentaPepsin and trypsinRYDF, YASGR and GNGSGYVSRIn vitro ACE inhibition assay & spontaneously hypertensive ratsIC50 values of 235, 184 and 29 μM respectively for RYDF, YASGR and GNGSGYVSRThree peptides inhibited ACE through non-competitive inhibition. GNGSGYVSR reduced systolic blood pressure 31 mmHg at 2 h after oral administration in spontaneously hypertensive rats.[59]
Phascolosoma esculentaPepsin and trypsinGNGSGYV and SRIn vitro ACE inhibition assayIC50 value of 170 μMGNGSGYV and SR showed ACE inhibition through synergistic effect. SR initially attacked the catalytic Zn of ACE and formed coordinate bond, and then GNGSGYV attached with the residues of ACE active site by hydrogen bonds.[17]
Table
Table 6. Molecular mechanisms of immunomodulatory activity of polysaccharides derived from peanut worms.
Table 6. Molecular mechanisms of immunomodulatory activity of polysaccharides derived from peanut worms.
SourceComposition of Polysaccharide ExtractCell Culture/
Animal Models		Dose and DurationMolecular Mechanisms/EffectsRef.
Phascolosoma esculenta------------Mice model3.0, 6.0, 9.0 mg/kgBW for 2 monthsPolysaccharides from P. esulenta significantly enhanced liver, spleen and thymus index of mice and increased Con A-stimulated mouse spleen cells.[64]
Sipunculus nudusMonosaccharide composition -rhamnose (28%), fucose (16%) and galactose (56%)Murine macrophages from BALB/c mice and human macrophages5–80 µg/mL for 24 hThe water soluble polysaccharide isolated from S. nudus showed immunostimulating activity by activating macrophages through the upregulation of expression of cytokines, IL-6 and TNF-α, and inducing the expression of iNOS and COX-2.[65]
Sipunculus nudus------------Mice------------Polysaccharides from Sipunculus nudus promoted the cellular immunity and humoral immunity through the enhancing the phagocytosis function and NK cell activity in mice.[66]
Sipunculus nudusL-rhamnose, Larabinose, D-ribose, D-glucose and D-galactoseHepatoma HepG2-bearing Mice50,100, and 200 mg/kg, 1 monthPolysaccharide extract from Sipunculus nudus enhanced the immune response through increase of thymus and spleen indexes, and upregulating the IL-2, IFN-γ, and TNF-α cytokines in serum of mice.[67]
Sipunculus nudusRepeating units are →3,4-β-D-GlcpNAC (1→ and →4)-α-D-Glcp (1→ in the ratio of 15:1; →2)-α-D-Galp-(1→ as a side chain; and β-D-Galp-(1→ and α-D-Glcp-(1→ as end groupshepatoma HepG2-bearingmice50,100, and 200 mg/kg, 16 daysPolysaccharide increased the index of immune organs and augmented the secretion of cytokines IL-2, IFN-γ and TNF-α.[18]
Table
Table 7. Molecular mechanisms of anti-cancer activity of polysaccharides derived from various peanut worms.
Table 7. Molecular mechanisms of anti-cancer activity of polysaccharides derived from various peanut worms.
SourceComposition of Polysaccharide ExtractCell Culture/
AnimalModels		Dose and DurationMolecular Mechanisms/EffectsRef.
Sipunculus nudusExtractcontains 35.3% neutral sugar, including Ara 10.7%, Rha 12.6%, Gal 16.4%, Glu 31.3%, Xyl 18.2%, and Man 10.8%.Hepg2.2.15 cells0.13, 0.25, 0.5, and 1 mg/mL for 24 and 48 hPolysaccharides showed anti-cancer activities by preventing the DNA synthesis of Hepg2.2.15 cells and increasing the expression of pro-apoptosis proteins, TNF-α, caspase-3, and Bax, and decreasing the expression of the anti-apoptosis proteins survivin, Bcl-2, and VEGF.[73]
Sipunculus nudusL-rhamnose, Larabinose, D-ribose, D-glucose and D-galactoseHepatoma HepG2-bearing Mice50,100, and 200 mg/kg, 1 monthPolysaccharides showed anti-tumor activity by inhibiting the growth of HepG2 cells through increase of ATF4, DDIT3, and IkBα expression and decrease of CYR61, HSP90, and VEGF expression.[67]
Sipunculus nudusRepeating units of →3,4-β-D-GlcpNAC
(1→ and →4)-α-D-Glcp(1→ in the ratio of 15:1; →2)-α-D-Galp-(1→ as a side chain; and β-D-Galp-(1→ and α-D-Glcp-(1→ as end groups		hepatoma HepG2-bearing
mice		50,100, and 200 mg/kg, 16 daysExtracted polysaccharide enhanced the apoptosis of tumour cells through the mitochondrial apoptosis pathway by upregulating caspase-3, caspase-8, caspase-9 and BCL2-associated X, and downregulating B-cell lymphoma-2 and vascular endothelial growth factor protein expression.[18]
Table
Table 8. Anti-hypoxia activity of polysaccharides derived from various peanut worms.
Table 8. Anti-hypoxia activity of polysaccharides derived from various peanut worms.
SourceComposition of Polysaccharide ExtractCell Culture/
Animal Models		Dose and DurationMolecular Mechanisms/EffectsRef.
Sipunculus nudusRhamnose (28%), fucose (16%) and galactose (56%).Mice model10, 30, 100 mg/kg for 6 daysThe extracted polysaccharide exhibited significant anti-hypoxic activity on normobarie hypoxia, chemical intoxicant hypoxia and acute cerebral ischemia hypoxia models in mice.[14]
Table
Table 9. Effects of peptides derived from peanut worms on wound healing and spatial learning and memory.
Table 9. Effects of peptides derived from peanut worms on wound healing and spatial learning and memory.
Peanut Worm NameEnzyme Used to Produce PeptidesPeptide Sequence and Molecular WeightIn Vitro/Cell Culture/Animals/Humans Used for the StudyDose and DurationMechanism of Action/Activities/Effects ShowedRef.
Sipunculus
nudus		Animal hydrolytic protease (3000 U/g) and flavor protease
(3000 U/g)		Collagen peptides < 5 kDahuman umbilical vein endothelial cells (HUVEC), human immortalized keratinocytes (HaCaT) and human skin fibroblasts (HSF) and mice2 g/mL for 28 days and 500 µg/mL for 12, 24, 30, 36 hCollagen peptides derived from Sipunculus nudus exhibited great capacity to induce HUVEC, HaCaT and HSF cells proliferation and migration in vitro. Peptides noticeably improved the healing rate and inhibited scar formation in mice through the mechanisms of reducing inflammation, enhancing collagen deposition and recombination and blockade of the TGF-β/Smads signal pathway.[20]
Phascolosoma esculentaPancreatinPeptides < 3 kDaMice50, 100 and 150 mg/kg for 15 daysPeptides improved the spatial learning and memory ability doses-dependently through the up-regulation of NR2A, NR2B, BDNF and CREB mRNA expressions in hippocampus of mice. 100 mg/kg group showed better performance in spatial learning and memory compared with 50, and 150 mg/kg.[15]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Qi, Y.; Zhou, J.; Shen, X.; Chalamaiah, M.; Lv, S.; Luo, H.; Chen, L. Bioactive Properties of Peptides and Polysaccharides Derived from Peanut Worms: A Review. Mar. Drugs 2022, 20, 10. https://doi.org/10.3390/md20010010

AMA Style

Qi Y, Zhou J, Shen X, Chalamaiah M, Lv S, Luo H, Chen L. Bioactive Properties of Peptides and Polysaccharides Derived from Peanut Worms: A Review. Marine Drugs. 2022; 20(1):10. https://doi.org/10.3390/md20010010

Chicago/Turabian Style

Qi, Yi, Jingyi Zhou, Xiaoqin Shen, Meram Chalamaiah, Simin Lv, Hui Luo, and Liang Chen. 2022. "Bioactive Properties of Peptides and Polysaccharides Derived from Peanut Worms: A Review" Marine Drugs 20, no. 1: 10. https://doi.org/10.3390/md20010010

APA Style

Qi, Y., Zhou, J., Shen, X., Chalamaiah, M., Lv, S., Luo, H., & Chen, L. (2022). Bioactive Properties of Peptides and Polysaccharides Derived from Peanut Worms: A Review. Marine Drugs, 20(1), 10. https://doi.org/10.3390/md20010010

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop